Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Differences and similarities between cancer and somatic stem cells: therapeutic implications

    Over the last decades, the cancer survival rate has increased due to personalized therapies, the discovery of targeted therapeutics and novel biological agents, and the application of palliative treatments. De...

    Fiorella Rossi, Hunter Noren, Richard Jove in Stem Cell Research & Therapy (2020)

  2. No Access

    Article

    Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

    Vascular endothelial growth factor (VEGF) upregulation is induced by many receptor and intracellular oncogenic proteins commonly activated in cancer, rendering molecular targeting of VEGF expression a complex ...

    Qing Xu, Jon Briggs, Sungman Park, Guilian Niu, Marcin Kortylewski in Oncogene (2005)

  3. No Access

    Article

    Stat3 regulates genes common to both wound healing and cancer

    Wound healing and cancer are both characterized by cell proliferation, remodeling of extracellular matrix, cell invasion and migration, new blood vessel formation, and modulation of blood coagulation. The mech...

    Daniel J Dauer, Bernadette Ferraro, Lanxi Song, Bin Yu, Linda Mora in Oncogene (2005)

  4. No Access

    Article

    Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity

    Constitutive activation of the JAK/STAT3 pathway is a major contributor to oncogenesis. In the present study, structure–activity relationship (SAR) studies with five cucurbitacin (Cuc) analogs, A, B, E, I, and...

    Jiazhi Sun, Michelle A Blaskovich, Richard Jove, Sandra K Livingston in Oncogene (2005)

  5. No Access

    Article

    Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells

    Stat3 (signal transducer and activator of transcription-3) activity is required for transformation by a number of oncogenes, while a constitutively active form of Stat3 alone is sufficient to induce neoplastic...

    Adina Vultur, Jun Cao, Rozanne Arulanandam, James Turkson, Richard Jove in Oncogene (2004)

  6. No Access

    Article

    Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

    Overexpression of receptor tyrosine kinases including the epidermal growth factor receptor (EGF-R) as well as nonreceptor tyrosine kinases, such as Src, have been implicated in the formation of human lung canc...

    Lanxi Song, James Turkson, James G Karras, Richard Jove, Eric B Haura in Oncogene (2003)

  7. No Access

    Chapter

    STAT Proteins as Molecular Targets for Cancer Therapy

    Constitutive activation of the STAT family members, Stat3 and Stat5, occurs at very high frequency in diverse human cancers. Persistent STAT signaling in tumor cells has been shown to increase the expression o...

    Ralf Buettner, Marcin Kortylewski in Signal Transducers and Activators of Trans… (2003)

  8. No Access

    Article

    Inhibition of Bcr–Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells

    Chronic myelogenous leukemia (CML) is a myeloproliferative disease characterized by the BCR–ABL genetic translocation and constitutive activation of the Abl tyrosine kinase. Among members of the Signal Transdu...

    Mei Huang, Jay F Dorsey, PK Epling-Burnette, Ramadevi Nimmanapalli in Oncogene (2002)

  9. No Access

    Article

    Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

    Activation of protein tyrosine kinases is prevalent in human cancers and previous studies have demonstrated that Stat3 signaling is a point of convergence for many of these tyrosine kinases. Moreover, a critic...

    Guilian Niu, Tammy Bowman, Mei Huang, Steve Shivers, Douglas Reintgen in Oncogene (2002)

  10. No Access

    Article

    Identification of Src transformation fingerprint in human colon cancer

    We used a classical rodent model of transformation to understand the transcriptional processes, and hence the molecular and cellular events a given cell undergoes when progressing from a normal to a transforme...

    Renae L Malek, Rosalyn B Irby, Qingbin M Guo, Kerry Lee, Sylvia Wong, Mei He in Oncogene (2002)

  11. No Access

    Article

    MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage

    MEK kinase 1 (MEKK1) induces apoptosis through the activation of caspases. The mechanism for MEKK1-induced apoptosis involves caspase-mediated cleavage of MEKK1, releasing a pro-apoptotic 91 kDa kinase fragmen...

    Andrea H Bild, Francisco J Mendoza, Erika M Gibson, Mei Huang in Oncogene (2002)

  12. No Access

    Article

    Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

    Non-receptor and receptor tyrosine kinases, such as Src and EGF receptor (EGFR), are major inducers of vascular endothelial growth factor (VEGF), one of the most potent mediators of angiogenesis. While tyrosin...

    Guilian Niu, Kenneth L Wright, Mei Huang, Lanxi Song, Eric Haura, James Turkson in Oncogene (2002)

  13. No Access

    Article

    Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis

    Hepatocyte Growth Factor/Scatter Factor (HGF/SF) mediates a wide variety of cellular responses by acting through the Met tyrosine kinase receptor. Inappropriate expression of HGF/SF and/or Met has been found i...

    Yu-Wen Zhang, Ling-Mei Wang, Richard Jove, George F Vande Woude in Oncogene (2002)

  14. No Access

    Article

    Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

    Constitutive activation of signal transducer and activator of transcription (STAT) proteins has been detected in a wide variety of human primary tumor specimens and tumor cell lines including blood malignancie...

    Roy Garcia, Tammy L Bowman, Guilian Niu, Hua Yu, Sue Minton in Oncogene (2001)

  15. No Access

    Article

    STAT proteins: novel molecular targets for cancer drug discovery

    Signal Transducers and Activators of Transcription (STATs) are a family of cytoplasmic proteins with roles as signal messengers and transcription factors that participate in normal cellular responses to cytoki...

    James Turkson, Richard Jove in Oncogene (2000)

  16. No Access

    Article

    Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling

    While the activated viral Src oncoprotein, v-Src, induces uncontrolled cell growth, the mechanisms underlying cell cycle deregulation by v-Src have not been fully defined. Previous studies demonstrated that v-...

    Dominic Sinibaldi, Walker Wharton, James Turkson, Tammy Bowman in Oncogene (2000)

  17. Article

    Guest Editor

    Richard Jove in Oncogene (2000)

  18. No Access

    Article

    Preface: STAT signaling

    Richard Jove in Oncogene (2000)

  19. No Access

    Article

    STATs in oncogenesis

    Since their discovery as key mediators of cytokine signaling, considerable progress has been made in defining the structure-function relationships of Signal Transducers and Activators of Transcription (STATs)....

    Tammy Bowman, Roy Garcia, James Turkson, Richard Jove in Oncogene (2000)

  20. No Access

    Article

    Activation of Stat3 preassembled with platelet-derived growth factor β receptors requires Src kinase activity

    Members of the STAT family of transcriptional regulators modulate the expression of a variety of gene products that promote cell proliferation, survival and transformation. Although initially identified as med...

    Yi-Zhe Wang, Walker Wharton, Roy Garcia, Alan Kraker, Richard Jove, W J Pledger in Oncogene (2000)

previous disabled Page of 2